Community Pharmacy Foundation

The APhA Foundation is proud to announce the 2022 Incentive Grant Digest. The digest highlights last cycle's projects along with additional facts, figures, and information on the program.

The APhA Foundation Incentive Grant Program is supported in part by Community Pharmacy Foundation.

To view the digest, please visit this link:https://www.aphafoundation.org/sites/default/files/ckeditor/files/APhA%20Foundation%202022%20Incentive%20Grant%20Digest(1).pdf

The next grant submission deadline is fast approaching and Community Pharmacy Foundation is looking for the next great idea to advance the practice of in the community setting. Apply by October 31 at midnight PST.

What CPF Funds What CPF Funds

Community Pharmacy Foundation In-Study Grant
Title: Determining Essential Elements and Capabilities for a Patient Record in Community Pharmacy
The specific objectives for this project are to: 1) Convene a panel of experts and use a Delphi method to develop a list of functional data elements and capabilities for a patient record in community pharmacy 2) Collect and aggregate best practices for documenting patient care services, and 3) Develop a rubric to assess community pharmacy documentation systems
Grantee: Hannah Fish, PharmD, CPHQ National Community Pharmacists Association
Learn More: http://ow.ly/ohx050IJb8s

Over-the-counter products have traditionally been for acute, self-limiting conditions. With a proposed rule, however, the U.S. Food and Drug Administration has indicated flexibility in allowing for OTC use of certain prescription medications for chronic diseases or conditions, such as high cholesterol, diabetes, and high blood pressure. Learn More:

FDA rule would facilitate prescription-to-OTC switches but nix a third class of drugs After a decade-long wait, the FDA has finally issued a proposed rule that would make it easier to switch products from prescription-only to over-the-counter status while still retaining a prescription version.

Scientists at The Ohio State University Wexner Medical Center, Ohio State University College of Medicine & University of Michigan Medical School examined how individuals with OUD are affected by central sensitization. The study provides the first evidence of central sensitization underlying the chronic pain and opioid use disorder relationship. Learn More:

What Drives Link Between Chronic Pain and Opioid Use Disorder Patients with central sensitization struggle more with pain and quitting opioids